Warning: DOMDocument::load(http://www.iovs.org/rss/current.xml) [domdocument.load]: failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found in /pub/home/eyenews/eyenews_ru/site/plugins/news/classess/news.inc.php on line 322

Warning: DOMDocument::load() [domdocument.load]: I/O warning : failed to load external entity "http://www.iovs.org/rss/current.xml" in /pub/home/eyenews/eyenews_ru/site/plugins/news/classess/news.inc.php on line 322

Warning: Cannot modify header information - headers already sent by (output started at /pub/home/eyenews/eyenews_ru/site/plugins/news/classess/news.inc.php:322) in /pub/home/eyenews/eyenews_ru/site/Site.inc.php on line 271

Warning: Cannot modify header information - headers already sent by (output started at /pub/home/eyenews/eyenews_ru/site/plugins/news/classess/news.inc.php:322) in /pub/home/eyenews/eyenews_ru/site/Site.inc.php on line 273
Проленса! Prolensa! - eyeNEWS — Все новости офтальмологии. Версия 6.0
АйНьюс.РФ
Конгресс
santen
Первая пятница декабря
Основные мероприятия ассоциации офтальмологов
bannerparasol
YouTube
Торика
oftalmolog_club
Beaver
appstore
профессор
askin_heid
Ассоциации
facebook
eye5
Mobile
varthamana2
glaucoma_net_ru
Конгресс 2014
medlab
Флаги
ВК
Главная / Новости / Проленса! Prolensa!
4 месяца назад
10 марта 2016

Проленса! Prolensa!

IMPORTANT SAFETY INFORMATION ABOUT PROLENSA

  • PROLENSA contains sodium sulfite, a sulfite that may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

  • All topical nonsteroidal anti-inflammatory drugs (NSAIDs), including bromfenac, may slow or delay healing. Concomitant use of topical NSAIDs and topical steroids may increase the potential for healing problems.

  • There is the potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other NSAIDs, including bromfenac. Use with caution in patients who have previously exhibited sensitivities to these drugs.

  • There have been reports that ocularly applied NSAIDs may cause increased bleeding of ocular tissues (including hyphemas) in conjunction with ocular surgery. Use with caution in patients with known bleeding tendencies or who are receiving other medications which may prolong bleeding time.

  • Use of topical NSAIDs may result in keratitis. Patients with evidence of corneal epithelial breakdown should immediately discontinue use of topical NSAIDs, including bromfenac, and should be closely monitored for corneal health. Patients with complicated ocular surgeries, corneal denervation, corneal epithelial defects, diabetes mellitus, ocular surface diseases (e.g., dry eye syndrome), rheumatoid arthritis, or repeat ocular surgeries within a short period of time may be at increased risk for corneal adverse events which may become sight threatening. Topical NSAIDs should be used with caution in these patients. Post-marketing experience with topical NSAIDs suggests that use more than 24 hours prior to surgery or use beyond 14 days post-surgery may increase patient risk for the occurrence and severity of corneal adverse events.

     

    читать далее на http://www.bausch.com/ecp/our-products/rx-pharmaceuticals/rx-pharmaceuticals/prolensa-bromfenac-ophthalmic-solution 


Warning: Cannot modify header information - headers already sent by (output started at /pub/home/eyenews/eyenews_ru/site/plugins/news/classess/news.inc.php:322) in /pub/home/eyenews/eyenews_ru/cms/includes/utils/Cookie.inc.php on line 60
Голосование
Что "заставляет" Вас заниматься научными исследованиями?